Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box

被引：18
|
作者：
Vanfleteren, Lowie E. G. W. [1 ]
Ullman, Anders [1 ]
Nordenson, Anita [1 ]
Andersson, Anders [1 ]
Andelid, Kristina [1 ]
Fabbri, Leonardo M. [1 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, COPD Ctr, Gothenburg, Sweden
来源：
ERJ OPEN RESEARCH | 2019年 / 5卷 / 01期
关键词：
OBSTRUCTIVE PULMONARY-DISEASE; DOUBLE-BLIND; FLUTICASONE FUROATE; INHALED BUDESONIDE; PARALLEL-GROUP; EXACERBATIONS; VILANTEROL; MODERATE; RISK; GLUCOCORTICOIDS;
D O I：
10.1183/23120541.00185-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
    Vanfleteren, Lowie
    Fabbri, Leonardo M.
    Papi, Alberto
    Petruzzelli, Stefano
    Celli, Bartolome
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3971 - 3981
  • [2] Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
    Singh, Dave
    Fabbri, Leonardo M.
    Vezzoli, Stefano
    Petruzzelli, Stefano
    Papi, Alberto
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 531 - 546
  • [3] Analysys Of The Clinical Feature Of COPD Patients With Triple Therapy(ics/laba/lama)
    Miyazaki, M.
    Nakamura, H.
    Sasaki, M.
    Haraguchi, M.
    Chubachi, S.
    Takahashi, S.
    Yoshida, S.
    Shirahata, T.
    Asano, K.
    Betsuyaku, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [4] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
    Calzetta, Luigino
    Cazzola, Mario
    Matera, Maria Gabriella
    Rogliani, Paola
    [J]. CHEST, 2019, 155 (04) : 758 - 770
  • [5] Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
    Tariq, Syed Mohammad
    Thomas, Enson C.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 1877 - 1882
  • [6] EVELUT®: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, R.
    Dreher, M.
    Mattiucci-Guehlke, M.
    Eckhardt, S.
    Taube, C.
    Vogelmeier, C.
    Buhl, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD
    Aoyama, Junichi
    Tanaka, Yosuke
    Kosaihira, Seiji
    Okano, Tetuya
    Hino, Mitunori
    Seike, Masahiro
    Gemma, Akihiko
    [J]. RESPIROLOGY, 2019, 24 : 165 - 165
  • [8] EFFECTIVENESS OF COPD MAINTENANCE THERAPY WITH LAMA/LABA VS LAMA/LABA/ICS IN A UNITED STATES CLAIMS DATABASE
    Quint, Jennifer
    Montonen, Jukka
    He, Xintong
    de la Hoz, Alberto
    Esposito, Daina
    [J]. CHEST, 2021, 160 (04) : 1863A - 1864A
  • [9] Single Inhaler Triple-Therapy (ICS/LAMA/LABA) Versus Dual-Therapy (ICS/LABA or LAMA/LABA) in Patients with COPD at Risk of Exacerbations: Efficacy and Safety Results of the Phase III IMPACT Trial
    Lipson, D. A.
    Barnhart, F.
    Brealey, N.
    Day, N. C.
    Brooks, J.
    Criner, G.
    Dransfield, M. T.
    Halpin, D. M.
    Han, M. K.
    Jones, C.
    Kilbride, S.
    Lange, P.
    Lomas, D. A.
    Martinez, F. J.
    Singh, D.
    Tabberer, M.
    Wise, R. A.
    Pascoe, S. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials
    Mehta, R.
    Farrell, C.
    Kilbride, S.
    Zhu, C.
    Brooks, J.
    Barnhart, F.
    Birk, R.
    Lipson, D. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345